MedTech Innovator

Type

Accelerator/Incubator

Status

Active

Location

Los Angeles, United States

Total investments

385

Average round size

94K

Portfolio companies

367

Rounds per year

35.00

Lead investments

122

Follow on index

0.05

Exits

12

Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalTherapeutics

Summary

MedTech Innovator is the famous Corporate Investor, which was founded in 2016. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Los Angeles.

The top amount of exits for fund were in 2018. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in 13-24 investment rounds annually. This MedTech Innovator works on 24 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 18 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2017. The average startup value when the investment from MedTech Innovator is 5-10 millions dollars.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the MedTech Innovator, startups are often financed by Dreamit Ventures, Alliance of Angels, TMCx Accelerator. The meaningful sponsors for the fund in investment in the same round are MassChallenge, Houston Angel Network, HealthTech Capital. In the next rounds fund is usually obtained by StartX (Stanford-StartX Fund), MassChallenge, Delta Partners.

The fund was created by Paul Grand.

Among the most popular portfolio startups of the fund, we may highlight Redox, Swift Health Systems, Neural Analytics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Medical Device, Sensor. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

Show more

Investor highlights

Stage focus
Series ASeries BSeries CSeries DSeries E
Geo focus
AustraliaCambodiaChinaIndiaIndonesia Show 10 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
385
Lead investments
122
Exits
12
Rounds per year
35.00
Follow on index
0.05
Investments by industry
  • Health Care (268)
  • Medical Device (224)
  • Medical (161)
  • Biotechnology (96)
  • Health Diagnostics (47)
  • Show 119 more
Investments by region
  • United States (258)
  • United Kingdom (17)
  • Israel (16)
  • Germany (6)
  • Canada (15)
  • Show 21 more
Peak activity year
2024
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
7M
Group Appearance index
0.07
Avg. company exit year
6
Avg. multiplicator
2.84
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
American BioOptic 17 Jun 2019 Health Care Seed United States, Illinois
Avisi Technologies 17 Jun 2019 Health Care, Medical Device, Nanotechnology Seed 50K United States, Pennsylvania, Philadelphia
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.